These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4847123)

  • 21. [Morphofunctional characteristics of erythrocytes in extracorporeal efferent detoxication].
    Samoĭlov MV; Mishnev OD; Kudriavtsev IuV; Naumov AG; Danilkov AP
    Klin Lab Diagn; 2002 Aug; (8):19-23. PubMed ID: 12362634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative characteristics of hemostasis system in patients with endstage renal disease admitted for urgent and elective hemodialysis].
    Kotliarova GV; Kozlovskaia NL; Lashutin SV; Komiagin IuV; Shakhnova EA; Dobromyslov IA; Shilov EM; Nesterova SG
    Ter Arkh; 2011; 83(6):36-41. PubMed ID: 21786574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of middle molecules in uremic patients.
    Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
    Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
    Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
    Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The serum gastrin level in the uraemic patients during haemodialysis (author's transl)].
    Pointner H; Flegel U; Schmidt P; Zazgornik J; Kopsa H; Waldhäusl W
    Wien Klin Wochenschr; 1974 Nov; 86(22):697-9. PubMed ID: 4460393
    [No Abstract]   [Full Text] [Related]  

  • 26. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
    Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
    [No Abstract]   [Full Text] [Related]  

  • 27. High-performance liquid chromatographic analysis of guanidino compounds using ninhydrin reagent. II. Guanidino compounds in blood of patients on haemodialysis therapy.
    Hiraga Y; Kinoshita T
    J Chromatogr; 1985 Aug; 342(2):269-75. PubMed ID: 4055949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological course of uraemic neuropathy in haemodialysis patients.
    Ogura T; Makinodan A; Kubo T; Hayashida T; Hirasawa Y
    Postgrad Med J; 2001 Jul; 77(909):451-4. PubMed ID: 11423596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
    Brunner H; Mann H; Essers U; Schultheis R; Byrne T; Heintz R
    Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leucocyte sodium transport in uraemia.
    Edmondson RP; Hilton PJ; Jones NF; Patrick J; Thomas RD
    Clin Sci Mol Med; 1975 Sep; 49(3):213-6. PubMed ID: 1175337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research on some erythrocytic abnormalities in chronic uremic patients in conservative and dialytic therapy].
    Lamperi S; Sitia L; Bandiani G; Muttini P
    Minerva Nefrol; 1970; 17(6):175-80. PubMed ID: 5516050
    [No Abstract]   [Full Text] [Related]  

  • 33. Factor VIII complex in uraemia and effects of haemodialysis.
    Turney JH; Woods HF; Fewell MR; Weston MJ
    Br Med J (Clin Res Ed); 1981 May; 282(6277):1653-6. PubMed ID: 6786417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure.
    Makita Z; Bucala R; Rayfield EJ; Friedman EA; Kaufman AM; Korbet SM; Barth RH; Winston JA; Fuh H; Manogue KR
    Lancet; 1994 Jun; 343(8912):1519-22. PubMed ID: 7911868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The advanced glycation endproduct pentosidine and monocyte activation in uremia.
    Friedlander MA; Witko-Sarsat V; Nguyen AT; Wu YC; Labrunte M; Verger C; Jungers P; Descamps-Latscha B
    Clin Nephrol; 1996 Jun; 45(6):379-82. PubMed ID: 8793229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do erythrocyte sedimentation rate and C-reactive protein levels have diagnostic usefulness in patients with renal failure?
    Arik N; Bedir A; Günaydin M; Adam B; Halefi I
    Nephron; 2000 Oct; 86(2):224. PubMed ID: 11015011
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure.
    Lipshultz SE; Somers MJ; Lipsitz SR; Colan SD; Jabs K; Rifai N
    Pediatrics; 2003 Jul; 112(1 Pt 1):79-86. PubMed ID: 12837871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of N-monoacetylcystine in uraemic plasma.
    Gejyo F; Ito G; Kinoshita Y
    Clin Sci (Lond); 1981 Mar; 60(3):331-4. PubMed ID: 7237945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transformed and pathological red cells in endogenous intoxication and extracorporeal detoxication].
    Samoĭlov MV; Mishnev OD; Kudriavtsev IuV
    Arkh Patol; 2002; 64(5):36-40. PubMed ID: 12575540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
    Marttinen A; Pasternack A; Koivula T
    Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.